RXFP3 and lip and oral cavity carcinoma: In stark contrast, decreased RXFP3 expression suggests that oral cancer cells fail to perambulate increased DNA damage, a phenomenon that is associated with heightened metabolism and ROS production and occurs in response to ARG1 overexpression.